APA (7th ed.) Citation

DB, M., S, J., S, M., RA, S., M, P., LVS, B., . . . M, E. (2025). Anti-PD1 prolongs the response of PI3K and farnesyl transferase inhibition in HRAS- and PIK3CA-mutant head and neck cancers. Neoplasia (New York, N.Y.), 63, 101157. https://doi.org/10.1016/j.neo.2025.101157

Chicago Style (17th ed.) Citation

DB, Manikandan, et al. "Anti-PD1 Prolongs the Response of PI3K and Farnesyl Transferase Inhibition in HRAS- and PIK3CA-mutant Head and Neck Cancers." Neoplasia (New York, N.Y.) 63 (2025): 101157. https://doi.org/10.1016/j.neo.2025.101157.

MLA (9th ed.) Citation

DB, Manikandan, et al. "Anti-PD1 Prolongs the Response of PI3K and Farnesyl Transferase Inhibition in HRAS- and PIK3CA-mutant Head and Neck Cancers." Neoplasia (New York, N.Y.), vol. 63, 2025, p. 101157, https://doi.org/10.1016/j.neo.2025.101157.